Ok I am being unfair. Mgmt is just waiting for the right time to shower us with stock buy backs and divvies to reward us for our patience? Seriously that's an option so its a week+ till Christmas is our present(s) forthcoming? Is Jason ready to wow us? I hate to admit it but at times his nature is to see how fast he can get the hell thru with any Q&A. I understand getting up in front of folks can be a bit of a nervous time. So hope he can gain confidence in his discussions. At this point I have been led to believe we are sitting on one heck of an investment. Under the impression our mgmt team cobbled together a STUPENDOUS collection of assets. The futures so bright we gotta wear shades.. Looking forward to filling in the timelines and blanks soon. Entering full time retirement in 2 weeks. Looking forward to getting closer to my assets. Keep hearing the point made by Fortitude they hit a home run with this asset package timing was close to perfect. They would not be able to cobble together an asset package like this in the current environment . Timing was near perfect. I'm all in holding my breath for more results, plans and details. .My FORT is like KNOX. My I TUDE is On FIRE! Home Runs to clear the bases in 2023!
Spread the love. Be the first to like this post!
Recent FTCO News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/28/2023 09:44:48 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 02/28/2023 09:17:43 PM
- Amended Annual Report (10-k/a) • Edgar (US Regulatory) • 12/15/2022 10:21:52 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/01/2022 08:41:05 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 08/02/2022 08:07:28 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 05/20/2022 09:03:59 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 05/04/2022 08:08:27 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM